Text Size
29 studies found for:    "Hereditary hemorrhagic telangiectasia"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Screening Behavior in Adults With Hereditary Hemorrhagic Telangiectasia
Conditions: Osler-Rendu-Weber Disease;   Osler-Rendu Disease;   Telangiectasia, Hereditary Hemorrhagic
Intervention:
2 Recruiting Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
Conditions: Epistaxis;   Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Sodium tetradecyl sulfate (sotradecol)
3 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.
4 Recruiting Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
5 Recruiting Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
6 Withdrawn Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia (HHT);   Nosebleeds
Intervention: Drug: Ranibizumab
7 Recruiting Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Submucosal Bevacizumab
8 Recruiting Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Drug: Bevacizumab
9 Completed Phase III Randomized, Placebo-Controlled, Crossover Study of Soy Protein Isolate for Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: soy protein isolate
10 Completed Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
11 Completed Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Ectasia
Intervention: Drug: octreotide
12 Completed Hereditary Haemorrhagic Telangiectasia Flight Safety Study
Condition: Hereditary Haemorrhagic Telangiectasia
Interventions: Other: Aeroplane flight in the past- no active intervention for study;   Other: Questionnaire
13 Active, not recruiting Diet and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia (HHT)
Interventions: Other: Questionnaire on dietary history;   Other: Questionnaire on nosebleed severity;   Other: One week food diary generated by weighing foods;   Procedure: Blood tests for full blood count, albumin, and indices of nutritional status
14 Completed Anti-Estrogen Therapy for Hereditary Hemorrhagic Telangiectasia A Double-Blind Placebo-Controlled Clinical Trial
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention: Drug: Tamoxifen
15 Completed Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Conditions: Arteriovenous Malformation;   Hereditary Hemorrhagic Telangiectasia;   Hematochezia;   Melena
Intervention: Drug: Thalidomide
16 Not yet recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia (HHT).
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
17 Completed Studies of Hereditary Hemorrhagic Telangiectasia
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
18 Recruiting Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Conditions: HHT;   Morbus Osler;   Epistaxis
Interventions: Drug: Bevacizumab;   Drug: NaCl
19 Terminated
Has Results 		Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
Conditions: Anemia;   Liver Disease;   Hypoxemia
Interventions: Drug: Pegylated Interferon Alpha2b;   Other: Standard care
20 Completed The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
To Top

Previous Page Studies Shown (1-20) Next Page (21-29) Show next page of results
† Indicates status has not been verified in more than two years